FDA Inspection 1238162 — U.S. Food And Drug Administration (FDA) Institutional Review Board (IRB)
The FDA completed an inspection of U.S. Food And Drug Administration (FDA) Institutional Review Board (IRB) on May 8, 2024 in Silver Spring, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 8, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Silver Spring, MD (United States)
Additional Details
IRB